Since CNBC highlighted the stock's attractive valuation in August, shares have gained around 20%. Why we expect more upside ahead.
<small>Source: CNBC — read the original story there.</small>
Business
West Pharma earnings show it's more than a GLP-1 play. Why we see more upside
CNBC
October 29, 2026
15 views
Advertisement
How did this make you feel?
Related Articles
Never miss a story
Get the best of SpeakOX in your inbox. No spam, unsubscribe anytime.